- Home
- NATL vs MNKD Comparison
NATL vs MNKD Comparison
Compare NATL & MNKD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NATL
- MNKD
- Stock Information
- Founded
- NATL 2023
- MNKD 1991
- Country
- NATL United States
- MNKD United States
- Employees
- NATL N/A
- MNKD N/A
- Industry
- NATL
- MNKD Biotechnology: Pharmaceutical Preparations
- Sector
- NATL
- MNKD Health Care
- Exchange
- NATL Nasdaq
- MNKD Nasdaq
- Market Cap
- NATL 1.8B
- MNKD 1.6B
- IPO Year
- NATL N/A
- MNKD 2004
- Fundamental
- Price
- NATL $26.26
- MNKD $5.01
- Analyst Decision
- NATL Buy
- MNKD Buy
- Analyst Count
- NATL 3
- MNKD 6
- Target Price
- NATL $40.00
- MNKD $8.92
- AVG Volume (30 Days)
- NATL 538.5K
- MNKD 2.0M
- Earning Date
- NATL 03-03-2025
- MNKD 05-07-2025
- Dividend Yield
- NATL N/A
- MNKD N/A
- EPS Growth
- NATL N/A
- MNKD N/A
- EPS
- NATL 1.23
- MNKD 0.10
- Revenue
- NATL $4,317,000,000.00
- MNKD $285,504,000.00
- Revenue This Year
- NATL $3.85
- MNKD $14.66
- Revenue Next Year
- NATL $3.95
- MNKD $14.27
- P/E Ratio
- NATL $21.62
- MNKD $50.30
- Revenue Growth
- NATL 3.01
- MNKD 43.50
- 52 Week Low
- NATL $19.00
- MNKD $3.97
- 52 Week High
- NATL $35.50
- MNKD $7.63
- Technical
- Relative Strength Index (RSI)
- NATL 38.49
- MNKD 36.36
- Support Level
- NATL $27.06
- MNKD $5.16
- Resistance Level
- NATL $28.12
- MNKD $5.12
- Average True Range (ATR)
- NATL 0.88
- MNKD 0.14
- MACD
- NATL 0.17
- MNKD 0.00
- Stochastic Oscillator
- NATL 43.80
- MNKD 20.91
About NATL NCR Atleos Corporation
NCR Atleos Corp is financial technology company providing self-directed banking solutions to a customer base including financial institutions, merchants, manufacturers, retailers and consumers. Self-directed banking is a rapidly growing, secular trend that allows banking customers to transact seamlessly between various channels all for the same transaction. Their comprehensive solutions enable the acceleration of self-directed banking through ATM and interactive teller machine (ITM) technology, including software, services, hardware and its proprietary Allpoint network. Atleos manage its operations in the following segments which includes Self-Service Banking, Network, and Telecommunications abd Technology.
About MNKD MannKind Corporation
MannKind Corp is a biopharmaceutical company focused on the development and commercialization of inhaled therapeutic products for patients with diseases such as diabetes and pulmonary arterial hypertension. Its approved product, Afrezza (insulin human) Inhalation Powder, is an ultra-rapid-acting inhaled insulin used to improve glycemic control in adults with diabetes. The product consists of a dry powder formulation of human insulin delivered from a small portable inhaler.